Aptamer-decorated nanocarriers for viral adsorption: A special look at COVID-19 DOI Creative Commons

Somayeh Handali,

Mohsen Rezaei

Molecular Therapy — Nucleic Acids, Год журнала: 2024, Номер 35(3), С. 102310 - 102310

Опубликована: Авг. 15, 2024

Viral infections are one of the leading causes death in world. One main challenge fighting against these diseases is unavailability effective eradicating drugs and specific treatments. Nanocarriers aptamer-decorated nanocarriers designed to attach many targets, including viral particles. By lowering infectivity attachment capability, they add therapeutic values even without containing antiviral drugs. Nevertheless, nanoparticles (NPs) with encapsulated can display extra effects. Furthermore, it has been shown that aptamers bind particles nanocarriers, presenting promising approaches for identification viruses treatment infections. Although there no satisfying literature revealing strong potential nanotechnology COVID-19, following information provide new perspectives upcoming investigations pertaining developing aptamer-nanocarrier agents COVID-19.

Язык: Английский

Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Precision Medicine DOI Creative Commons
Anu Sharma, Anita Yadav,

Aparajita Nandy

и другие.

Pharmaceutics, Год журнала: 2024, Номер 16(6), С. 709 - 709

Опубликована: Май 24, 2024

Of all the numerous nanosized extracellular vesicles released by a cell, endosomal-originated exosomes are increasingly recognized as potential therapeutics, owing to their inherent stability, low immunogenicity, and targeted delivery capabilities. This review critically evaluates transformative of exosome-based modalities across pharmaceutical precision medicine landscapes. Because precise biomolecular cargo delivery, posited ideal candidates in drug enhancing regenerative strategies, advancing diagnostic technologies. Despite significant market growth projections exosome therapy, its utilization is encumbered substantial scientific regulatory challenges. These include lack universally accepted protocols for isolation complexities associated with navigating environment, particularly guidelines set forth U.S. Food Drug Administration (FDA). presents comprehensive overview current research trajectories aimed at addressing these impediments discusses prospective advancements that could substantiate clinical translation exosomal therapies. By providing analysis both capabilities hurdles therapeutic applications, this article aims inform direct future paradigms, thereby fostering integration systems into mainstream practice.

Язык: Английский

Процитировано

19

Advancements in Aptamer‐Driven DNA Nanostructures for Precision Drug Delivery DOI Creative Commons
Moein Safarkhani, Sepideh Ahmadi,

Hossein Ipakchi

и другие.

Advanced Science, Год журнала: 2024, Номер 11(26)

Опубликована: Май 7, 2024

Abstract DNA nanostructures exhibit versatile geometries and possess sophisticated capabilities not found in other nanomaterials. They serve as customizable nanoplatforms for orchestrating the spatial arrangement of molecular components, such biomolecules, antibodies, or synthetic This is achieved by incorporating oligonucleotides into design nanostructure. In realm drug delivery to cancer cells, there a growing interest active targeting assays enhance efficacy selectivity. The approach involves “key‐lock” mechanism where carrier, through its ligand, recognizes specific receptors on tumor facilitating release drugs. Various nanostructures, including origami, Tetrahedral, nanoflower, cruciform, nanostar, nanocentipede, nanococklebur, can traverse lipid layer cell membrane, allowing cargo nucleus. Aptamers, easily formed vitro, are recognized their targeted due high selectivity targets low immunogenicity. review provides comprehensive overview recent advancements formation modification aptamer‐modified within systems.

Язык: Английский

Процитировано

17

Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review DOI Creative Commons
Melinda-Ildiko Mitranovici, Laura Caravia,

Liviu Moraru

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(3), С. 277 - 277

Опубликована: Фев. 20, 2025

Increasing evidence shows that a very small population of cancer stem cells (CSCs) is responsible for recurrence, drug resistance, and metastasis. CSCs usually reside in hypoxic tumor regions are characterized by high tumorigenicity. Their inaccessible nature allows them to avoid the effects conventional treatments such as chemotherapy, radiotherapy, surgery. In addition, chemo- radiotherapy potentially toxic could help spread survive. New therapeutic targets against sought, including different signaling pathways distinct cell surface markers. Recent advances nanotechnology have provided hope development new avenues eradicate CSCs. this review, we present newly discovered nanoparticles can be co-loaded with an apoptosis-inducing agent or differentiation-inducing agent, stability, cellular penetration, release. We also summarize molecular characteristics their survival maintenance. Controlled release targeting aims reduce stemness-related suppress growth, prevent relapse metastases.

Язык: Английский

Процитировано

1

Biochemical and biophysical interaction of rare earth elements with biomacromolecules: A comprehensive review DOI
Rashmi Rekha Samal, Umakanta Subudhi

Chemosphere, Год журнала: 2024, Номер 357, С. 142090 - 142090

Опубликована: Апрель 20, 2024

Язык: Английский

Процитировано

8

Nanotechnology and nanobots unleashed: pioneering a new era in gynecological cancer management – a comprehensive review DOI
Naina Kumar, Mishu Mangla

Cancer Chemotherapy and Pharmacology, Год журнала: 2025, Номер 95(1)

Опубликована: Янв. 4, 2025

Язык: Английский

Процитировано

1

Revolutionizing Cancer Therapy using Tetrahedral DNA Nanostructures as Intelligent Drug Delivery Systems DOI Creative Commons
Ayushi Sharma, Payal Vaswani, Dhiraj Bhatia

и другие.

Nanoscale Advances, Год журнала: 2024, Номер 6(15), С. 3714 - 3732

Опубликована: Янв. 1, 2024

DNA nanostructures have surfaced as intriguing entities with vast potential in biomedicine, notably the drug delivery area.

Язык: Английский

Процитировано

5

MicroRNAs in metabolism for precision treatment of lung cancer DOI Creative Commons
Giovanna Carrà, Jessica Petiti,

Federico Tolino

и другие.

Cellular & Molecular Biology Letters, Год журнала: 2024, Номер 29(1)

Опубликована: Сен. 10, 2024

Язык: Английский

Процитировано

3

Recent advancements in biosensors for ovarian cancer detection including aptamer-based field-effect transistor sensors for CA125 and HE4 DOI
Johny Bajgai,

M.C. Jun,

Joon Hak Oh

и другие.

Talanta, Год журнала: 2025, Номер 292, С. 127954 - 127954

Опубликована: Март 15, 2025

Язык: Английский

Процитировано

0

The intersection of ferroptosis and non-coding RNAs: a novel approach to ovarian cancer DOI Creative Commons
Yi Jiang,

Tamara Nazar Saeed,

Karar H. Alfarttoosi

и другие.

European journal of medical research, Год журнала: 2025, Номер 30(1)

Опубликована: Апрель 17, 2025

Understanding the core principles of ovarian cancer has been significantly improved through exploration Ferroptosis, a type cell death triggered by iron that leads to an increase in lipid peroxides. Current research shed light on critical functions non-coding RNAs, such as circRNAs, lncRNAs, and miRNAs, regulating ferroptosis cancer. The aim this paper is comprehensively analyze how ncRNAs influence development cells. In-depth undertaken understand intricate ways which regulate essential elements ferroptosis, including management peroxidation levels. We also investigate their significant involvement progression cellular demise. It should be emphasized can impact synthesis crucial proteins, GPX4, key contributor defense against oxidation, ACSL4, involved formation. In addition, we examine correlation between well-known pathways associated with oxidative stress death. consequences these discoveries are noteworthy, since focusing particular could potentially render cells more vulnerable effectively combating drug resistance problems. This discussion highlights growing significance governing potential useful biomarkers treatment targets for intend promote additional into controlling based current findings, ultimate goal informing targeted therapeutic strategies improving long-term outcomes individuals suffering from OC.

Язык: Английский

Процитировано

0

Advancing ovarian cancer management: Role of nucleic acid biomarkers and novel therapeutic approaches DOI

Rutuja Deshmukh,

Sharav Desai,

Vipul Patel

и другие.

Gene Reports, Год журнала: 2025, Номер unknown, С. 102241 - 102241

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0